PSG-101
Parkinson's Disease (Motor Fluctuations)
Phase 2Active
Key Facts
About PharmaSGP
PharmaSGP is a clinical-stage biopharmaceutical company headquartered in Germany with a strategic focus on neurological and rare disease therapeutics. The company has built a diversified pipeline of novel drug candidates, primarily in Phase 2 development, targeting conditions such as Parkinson's disease, epilepsy, and rare genetic disorders. With a public listing providing financial stability, PharmaSGP combines scientific innovation with commercial execution to address complex medical challenges in specialized therapeutic areas.
View full company profile